{"id":"W2922392474","doi":"10.1182/blood.v130.suppl_1.2821.2821","title":"Addition of Polatuzumab Vedotin to Bendamustine and Rituximab (BR) Improves Outcomes in Transplant-Ineligible Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Versus BR Alone: Results from a Randomized Phase 2 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Diffuse large B-cell lymphoma; Refractory (planetary science); Internal medicine; Oncology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001756049,0.0007084322,0.001388455,0.0002951383,0.000236936,0.001147167,0.0005867562,0.0008724848,0.003187769],"category_scores_gemma":[0.001090639,0.0003862616,0.001766039,0.0003008888,0.0005618393,0.0007919352,0.0003608282,0.002520239,0.0005497909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006426077,"about_ca_system_score_gemma":0.0004978594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003226893,"about_ca_topic_score_gemma":0.0009628682,"domain_scores_codex":[0.9994282,0.0003078055,0.00004529088,0.00009518799,0.00005468877,0.00006879739],"domain_scores_gemma":[0.9990891,0.00024954,0.0002691527,0.00006416856,0.00005411642,0.0002739268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8889817,0.01547519,0.004920076,0.000973623,0.002832977,0.00006865115,0.00009504003,0.000603497,0.009129449,0.0001272747,0.001162624,0.07562993],"study_design_scores_gemma":[0.627794,0.3403447,0.02323313,0.0001626579,0.003107721,0.0001882305,0.00007174678,0.000742466,0.002073918,0.0002563434,0.00199191,0.00003322079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911916,0.006210196,0.0001767187,0.0004781157,0.0001479295,0.0004978745,0.0003500367,0.00003373446,0.00091384],"genre_scores_gemma":[0.9944373,0.002303744,0.0005140199,0.0006345013,0.0001847099,0.0004764157,0.0006546944,0.000008685351,0.0007858941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003187769,"threshold_uncertainty_score":0.01066417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01054081459692187,"score_gpt":0.2612747554390845,"score_spread":0.2507339408421627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}